Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma
Luke Horton,
No information about this author
Joseph W. Fakhoury,
No information about this author
Rayyan Manwar
No information about this author
et al.
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(5), P. 297 - 297
Published: May 7, 2025
Imaging
technologies
are
constantly
being
developed
to
improve
not
only
melanoma
diagnosis,
but
also
staging,
treatment
planning,
and
disease
progression.
We
start
with
a
description
of
how
is
characterized
using
histology,
then
continue
by
discussing
nearly
two
dozen
different
technologies,
including
systems
currently
used
in
medical
practice
those
development.
For
each
technology,
we
describe
its
method
operation,
it
or
would
be
projected
most
commonly
diagnosing
managing
melanoma,
for
current
use,
identify
at
least
one
manufacturer.
provide
table
the
biomarkers
identified
main
limitations
associated
technology
conclude
offering
suggestions
on
specific
characteristics
that
might
best
enhance
technology’s
potential
widespread
clinical
adoption.
Language: Английский
Recombinant humanized type III collagen inhibits ovarian cancer and induces protective anti-tumor immunity by regulating autophagy through GSTP1
Hui Zeng,
No information about this author
Hu Li,
No information about this author
Li Wang
No information about this author
et al.
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
28, P. 101220 - 101220
Published: Sept. 1, 2024
Ovarian
cancer
(OC)
is
one
of
the
leading
causes
death
from
malignancy
in
women
and
lacks
safe
efficient
treatment.
The
novel
biomaterial,
recombinant
humanized
collagen
type
III
(rhCOLIII),
has
been
reported
to
have
various
biological
functions,
but
its
role
OC
unclear.
This
study
aimed
reveal
function
mechanism
action
rhCOLIII
OC.
We
developed
an
injectable
human
(rhCOL)-derived
material
with
a
molecular
weight
45
kDa,
stable
triple
helix
structure,
high
biocompatibility,
water
solubility
biosafety.
anti-tumor
activity
was
comprehensively
evaluated
through
Language: Английский
Quantitative Assessment of Collagen Architecture to Determine Role of Tumor Stroma During Vestibular Schwannoma Progression
Melanie Fisher,
No information about this author
Bailey H. Duhon,
No information about this author
Han T. N. Nguyen
No information about this author
et al.
Otolaryngology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 7, 2024
Abstract
Objective
The
primary
objective
was
to
characterize
the
abundance
and
architecture
of
collagen
in
extracellular
matrix
vestibular
schwannoma
(VS).
secondary
investigate
association
between
tumor
size.
Study
Design
Retrospective
cohort
study.
Setting
Academic
referral
center.
Methods
Tumor
samples
were
obtained
from
patients
with
sporadic
VS
undergoing
microsurgical
resection.
Histological
analyses
performed
including
picrosirius
red
(PSR)
staining
under
polarized
light.
Collagen
quantified
using
an
automated
fiber
detection
software.
Second
Harmonic
Generation
(SHG)
microscopy
immunofluorescence
(IF)
utilized
architecture.
Results
Eleven
specimens
included
(mean
diameter
=
2.80
cm,
range
1.5‐4.0
cm),
divided
into
large
3.5
±
0.4
cm)
small
2.0
cohorts
based
on
showed
significantly
higher
density
(27.65%
vs
12.73%,
P
.0043),
more
thick
fibers
(mature
Type
I,
24.54%
12.97%,
.0022)
thin
(immature
I
or
mature
III,
23.55%
12.27%,
.026).
volume
correlated
greater
degree
disorganization
(
.0413,
r
2
0.298).
Specifically,
type
intensity
compared
tumors
<
.001)
peripheral
nerve
.028).
Conclusion
Larger
exhibit
increased
stroma,
a
disorganized
smaller
normal
tissue.
This
finding
indicates
that
organization
may
play
significant
role
remodeling
progression
VS.
Language: Английский
Collagen remodeling in murine melanoma therapy response through second-harmonic generation imaging
Biophotonics discovery.,
Journal Year:
2024,
Volume and Issue:
1(03)
Published: Dec. 17, 2024
The
study
by
Heaton
et
al.
marks
a
significant
advancement
in
understanding
the
role
of
collagen
remodeling
within
melanoma
tumor
microenvironment
during
immunotherapy.
Using
vivo
second-harmonic
generation
imaging,
authors
quantitatively
tracked
dynamic
changes
morphology
preclinical
model,
revealing
shift
toward
healthier
phenotype
associated
with
treatment.
These
findings
enhance
our
extracellular
matrix
dynamics
and
highlight
potential
optical
imaging
technologies
to
guide
optimize
cancer
This
commentary
will
explore
these
findings,
contextualize
them
broader
field
immunology,
discuss
their
implications
for
improving
immunotherapy
strategies
other
cancers.
Language: Английский